GlassScriptPhysician profile
Blake Austin Feil
NPI 1750619730
$769.49
in general payments reported to CMS, 2019-2025
9 companies · $246 in 2025
The $246 reported for 2025 was more than what a typical Orthodontics and Dentofacial Orthopedics provider received nationally (typical 2025 total: $146).
See the full distribution for Orthodontics and Dentofacial Orthopedics
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $155 · 2021: $124 · 2022: $40.77 · 2024: $204 · 2025: $246.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $450.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $450.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ormco Corporation | $233.81 | 2019-2022 | |
| Dentsply Sirona INC | $179.51 | 2024-2025 | Suresmile |
| Ortho Organizers, INC. | $91.31 | 2024 | |
| Gc America INC. | $82.12 | 2025 | Bio-Edge, Bio-Active |
| Align Technology, INC. | $75.11 | 2021 | |
| Envista Holdings Corporation | $44.23 | 2024-2025 | Miniendo II |
| American Orthodontics Corporation | $29.83 | 2025 | Master Series, Empower-Metal, LP and Ifit Tubes |
| Solventum Corporation | $23.20 | 2024 | Clarity Aligners |
| Voco America INC. | $10.37 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Blake Feil listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.